NETest®

About Wren Laboratories

Wren Laboratories is a pioneering diagnostics company specializing in mRNA-based liquid biopsy for oncology. Its core innovation is a proprietary RNA stabilization and testing platform that profiles multi-gene mRNA expression to detect active signaling pathways in tumors, offering insights for personalized cancer management and drug development. The company has launched two clinically validated tests, NETest® for neuroendocrine tumors and PROSTest® for prostate cancer, and is supported by an extensive intellectual property portfolio and numerous peer-reviewed publications. It operates as a certified laboratory service provider, serving both clinicians and biopharma partners.

Therapeutic Areas